While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

In R&D, leadership changed for the first time in 15 years, with Mikael Dolsten stepping down, and the team underwent a restructuring. Bourla also highlighted returns to shareholders, including ...

He is replacing Dr Mikael Dolsten whose departure from Pfizer was announced in July, bringing a 15-year-plus career at the pharma group to a close, effective 1st January. The shake-up in Pfizer's ...

and we will focus our efforts on gathering the data to understand its potential profile,” commented Mikael Dolsten, Pfizer’s chief scientific officer. There’s no question, however ...

Dr. Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten whose departure from Pfizer was announced earlier this year. In his new ...

Mikael Ymer kan snart göra comeback efter sin dopningsavstängning. Svensken kommer tas ut i det svenska laget i Davis Cup. – För svensk tennis är det väldigt roligt.